Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Other Nov 22 | 2019Sanofi Head of Strategy to Leave End of NovemberPurchase Blast
lilly cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucagon Nov 20 | 2019Lilly to Invest $400M in Diabetes ManufacturingPurchase Blast
novo cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Insulin Delivery, SGLT2i Nov 20 | 2019Novo 2019 Capital Markets Day Highlights and AnalysisPurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Nov 19 | 2019Sanofi Ends Sensile Medical Partnership; Onduo Parnters with Hidrate; Other Diabetes-Related NewsPurchase Blast
medtronic cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 19 | 2019Medtronic CY Q3 '19 (FY Q2 '20) Earnings UpdatePurchase Blast
onedrop cover image
$599
Posted in: Glucose Monitoring Nov 18 | 2019One Drop Showcases BG Prediction CapabilityPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, Other Nov 18 | 2019New Novo Partnership with Dicerna for RNAi TherapeuticsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Insulin Delivery, SGLT2i Nov 15 | 2019AZ's Qtrilmet Triple-combo Receives EC Approval; New Data from Fractyl, Dario, and ValeritasPurchase Blast
senseonics cover image
$599
Posted in: Glucose Monitoring Nov 12 | 2019Senseonics Q3 '19 Earnings UpdatePurchase Blast
1 2 3 4 32

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.